Communications with NIH

We wanted to be clear about our communications with NIH since there has been some conflicting information. The founders of #MEAction have never met with Dr Collins, Dr Koroshetz, Dr Nath, or anyone else on the intramural study. We have requested several times to meet with Dr Koroshetz and Dr Nath so that we could share the concerns of the community about many aspects of the intramural study, but have never had a meeting. We have spoken with Vicky Whittemore (member of the Trans-NIH Working Group and CFSAC) and Marian Emr (head of NINDS communications), but neither are involved in any way on the study. We sent in a summary of community questions and the 100+ comments about Walitt’s role on the study to Dr Collins, Koroshetz, and Nath. We have been told that the NIH is reading all emails that are coming in, but don’t know if and when we will get substantive responses to many of the issues that have been raised.
#MEAction and Mary Schweitzer plan on delivering the two petitions on the #MEAction platform about the study in the next week. Now is the perfect time to sign them if you agree with their requests:

Another method to get across your concerns is to ask Dr Nath questions at the April 21st webinar with Solve ME/CFS Initiative. You can register at https://attendee.gotowebinar.com/register/9009984691255834372, then send in questions.
 

Facebook
Twitter
WhatsApp
Email

Latest News

Blue square image with starbursts in the corners. the words, submit long covid drug recommendations to recover -tlc! are in the middle of the image, surrounded by thin white lines. the meaction logo is at the top of the image.

Submit Long COVID Drug Recommendations to RECOVER-TLC!

Last month, RECOVER TLC met at NIH headquarters in Bethesda. The goal was to initiate a drug development strategy for Long COVID clinical trials. Now, RECOVER TLC has opened the RECOVER-TLC Intervention Information Request Form, where you can make suggestions about which drugs and other interventions to trial!  Anyone can submit a therapeutic for consideration

Read More »
A classroom of people watching a panel discussion.

The RECOVER-Treating Long COVID (RECOVER TLC) The Path Forward

The RECOVER-Treating Long COVID (RECOVER TLC) Kick-off Meeting was Sept 23-25 in person and over Zoom. I had the privilege of attending over Zoom and Jaime Seltzer, #MEAction’s Scientific Director, represented the needs of the ME community in person and as an invited member of a panel on clinical trial design. There were many speakers

Read More »
Scroll to Top